Media Contact: Lissa Pavluk media@apellis.com (617) 977-6764 Year All20242023202220212020201920182017201620152014 August 8, 2016 Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer June 23, 2016 Apellis Announces Positive Results from Phase 1 Clinical Trials of APL-2, a C3 Complement Inhibitor